KNTE
Dimensional Fund Advisors’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-91,961
| Closed | -$245K | – | 3447 |
|
|
2024
Q1 | $245K | Buy |
91,961
+77,368
| +530% | +$206K | ﹤0.01% | 3164 |
|
|
2023
Q4 | $34.7K | Buy |
14,593
+2,344
| +19% | +$5.57K | ﹤0.01% | 3370 |
|
|
2023
Q3 | $17.1K | Sell |
12,249
-13,335
| -52% | -$18.6K | ﹤0.01% | 3448 |
|
|
2023
Q2 | $77.8K | Sell |
25,584
-6,962
| -21% | -$21.2K | ﹤0.01% | 3360 |
|
|
2023
Q1 | $203K | Sell |
32,546
-5,852
| -15% | -$36.5K | ﹤0.01% | 3198 |
|
|
2022
Q4 | $234 | Sell |
38,398
-510
| -1% | -$3 | ﹤0.01% | 3197 |
|
|
2022
Q3 | $465K | Buy |
38,908
+7,515
| +24% | +$89.8K | ﹤0.01% | 3062 |
|
|
2022
Q2 | $396K | Buy |
+31,393
| New | +$396K | ﹤0.01% | 3114 |
|